Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 3—March 2002

Human Campylobacteriosis in Developing Countries1

Akitoye O. Coker*Comments to Author , Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
Author affiliations: *University of Lagos, Idi-Araba, Lagos, Nigeria; †University of Venda for Science and Technology, Thohoyandon, South Africa;

Main Article

Table 4

Trends in Resistance to Ciprofloxacin by Campylobacter jejuni in selected developed countries up to year 2000

Country Period Resistance strains (%) Ref.
Initial Year 2000
Freiburg, Germany 1992-2000 22 32 41
Styria, Austria 1996-2000 25.2 40.2 42
England and Wales, UK 1993-2000 10 14.8 44
Philadelphia, USA 1995-2000 <10 36 45
Oslo, Norway 1988-2000 6.1 36 46

Main Article

1 Portions of this review were presented at the World Health Organization Consultation on the Increasing Incidence of Campylobacteriosis in Humans, Copenhagen, Denmark, November 1-25, 2000. In addition, relevant emerging information from the 11th International Workshop on Campylobacter, Helicobacter and Related Organisms, held in Freiburg, Germany, September 1-5, 2001, are included.

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.